>(((Joel Harris))), CEO and co-founder of Genvax Technologies, said in a release. “The goal is to develop a vaccine that matches 100% to the specific strain when a disease outbreak occurs." Because the gigantic worldwide mRNA experiment failing to prevent infection or transmission at a statistical significance greater than no treatment at all is an indication of total 100% success in all future endeavors of exactly the same type. Honk honk!